HomeAI · summaries
Storia in 20 fonti
Pancreatic cancer drug Daraxonrasib gets approval from FDA: All you need to know
FDA officials gave expedited approval to daraxonrasib, which blocks a mutated protein that fuels tumor growth
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
Rasonque nabs FDA approval for previously treated metastatic pancreatic adenocarcinoma
The FDA has approved a first-in-class targeted therapy for adults with metastatic pancreatic adenocarcinoma. Daraxonrasib (Rasonque, Revolution Medicines), an RAS inhibitor,…
- ·
forbes.com
FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque
Rasonque joins a short list of treatment options for one of the country’s deadliest types of cancer.
